Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | -3.32% | -25.14% | +12.93% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
Financials (USD)
Sales 2024 * | 35.91M | Sales 2025 * | 33.12M | Capitalization | 321M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -99M | EV / Sales 2024 * | 6.37 x |
Net cash position 2024 * | 91.88M | Net cash position 2025 * | 44.36M | EV / Sales 2025 * | 8.34 x |
P/E ratio 2024 * |
-3.9
x | P/E ratio 2025 * |
-3.58
x | Employees | 123 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.3% |
Latest transcript on Mersana Therapeutics, Inc.
1 day | -3.32% | ||
1 week | -25.14% | ||
Current month | -17.35% | ||
1 month | -31.23% | ||
3 months | -31.59% | ||
6 months | +109.60% | ||
Current year | +12.93% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 20-04-12 |
Director of Finance/CFO | 46 | 19-07-09 | |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 16-07-31 |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Anna Protopapas
BRD | Director/Board Member | 59 | 15-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +2.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 2.62 | -3.32% | 2,238,898 |
24-05-10 | 2.71 | +9.94% | 2,807,159 |
24-05-09 | 2.465 | -27.50% | 3,772,154 |
24-05-08 | 3.4 | -3.55% | 876,321 |
24-05-07 | 3.525 | +0.71% | 679,630 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.93% | 321M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.45% | 21.93B | |
-12.15% | 22.34B | |
-5.29% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- MRSN Stock